Insight Molecular Diagnostics (IMDX) Financial Statements & Analysis

Insight Molecular Diagnostics (IMDX) Income Statement

Insight Molecular Diagnostics reported revenue of $4.05M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 115.6% from $1.88M a year earlier. Insight Molecular Diagnostics posted a net loss of $50.22M, compared with a net loss of $60.66M a year earlier. Gross margin was 56.7% and operating margin -754.1%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $239.00K, down 53.9% from the same quarter a year earlier.

Insight Molecular Diagnostics Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Insight Molecular Diagnostics Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Mar 2024	Dec 2023	Mar 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Mar 2019	Dec 2017
Revenue & Gross Profit
Revenue	4.06	1.88	1.50	1.50	0.96	0.96	2.20	1.22	0.00	0.00	0.00
Cost of Revenue	1.76	1.14	1.09	1.00	0.98	0.98	0.70	1.86	0.34	0.56	0.58
Gross Profit	2.30	0.74	0.41	0.41	-0.02	-0.02	1.42	-0.64	-0.34	-0.56	-0.58
Operating Expenses
Research & Development	15.90	9.84	9.29	9.15	7.30	7.30	4.80	9.80	6.79	6.51	7.17
Selling, General & Administrative	16.11	13.79	13.29	13.54	21.53	21.53	20.39	23.28	15.45	8.69	11.68
Operating Expenses	32.88	61.78	25.55	25.55	17.98	28.83	55.15	29.07	22.24	15.20	18.85
Operating Income	-30.58	-61.04	-25.14	-25.14	-18.00	-28.85	-53.73	-29.71	-22.24	-15.20	-18.85
Other Income/Expense
Interest Income	0.00	0.00	0.00	-	0.00	-	0.00	0.00	0.30	0.00	0.00
Interest Expense	0.11	0.08	0.05	-0.05	0.08	0.08	-0.21	0.25	0.30	0.22	0.22
Other Income/Expense	-19.54	0.38	0.28	0.28	-0.62	10.32	0.85	-1.48	-0.19	-0.55	-0.53
Income
Income Before Tax	-50.22	-60.66	-24.86	-24.86	-18.61	-18.61	-52.87	-31.19	-22.43	-15.75	-19.38
Income Tax Expense	0.00	0.00	0.00	-	0.00	-	-9.26	-1.25	0.00	0.00	0.00
Net Income	-50.22	-60.66	-27.78	-27.78	-72.90	-72.90	-128.19	-29.93	-22.33	-15.75	-19.38
Net Income - Continuous Operations	-50.22	-60.66	-27.78	-24.86	-72.90	-18.61	-64.10	-29.93	-22.33	-15.75	-19.38
Net Income - Discontinued Operations	-	-	-	-2.93	-	-54.29	-20.49	-	-	-	-
EBITDA	-47.92	-59.02	-23.12	-20.59	-13.31	-13.31	-19.57	-30.54	-21.90	-15.20	-18.27
EBIT	-50.11	-60.58	-	-22.27	-	-18.53	-23.77	-32.51	-	-	-
Depreciation & Amortization	0.86	1.56	1.68	1.68	5.22	5.22	4.21	0.39	0.34	0.56	0.58
Earnings Per Share
Basic EPS	-2.00	-5.00	-4.00	-4.00	-20.00	-20.00	-14.00	-9.00	-9.00	-8.00	-13.00
Diluted EPS	-2.00	-5.00	-4.00	-4.00	-20.00	-20.00	-14.00	-9.00	-9.00	-8.00	-13.00
Basic Shares Outstanding	30.48	13.07	7.65	7.65	5.54	5.54	4.45	3.27	2.56	1.89	1.51
Diluted Shares Outstanding	30.48	13.07	7.65	7.65	5.54	5.54	4.45	3.27	2.56	1.89	1.51

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Insight Molecular Diagnostics Financial Statements

What was Insight Molecular Diagnostics's revenue in fiscal 2025?

Insight Molecular Diagnostics reported revenue of $4.05M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 115.6% from $1.88M a year earlier.

Is Insight Molecular Diagnostics profitable?

No. Insight Molecular Diagnostics reported a net loss of $50.22M in fiscal 2025. In fiscal 2024 it lost $60.66M.

What is Insight Molecular Diagnostics's operating margin?

Insight Molecular Diagnostics's operating income was −$30.58M on revenue of $4.05M in fiscal 2025, an operating margin of -754.1%, compared with -3245.1% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition